580 related articles for article (PubMed ID: 10401019)
1. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
[TBL] [Abstract][Full Text] [Related]
3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
5. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
Aoun B; Decramer S; Vitkevic R; Wannous H; Bandin F; Azema C; Callard P; Brocheriou I; Ulinski T
Pediatr Nephrol; 2013 Mar; 28(3):493-8. PubMed ID: 23111894
[TBL] [Abstract][Full Text] [Related]
6. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
7. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
Solez K; Vincenti F; Filo RS
Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
[TBL] [Abstract][Full Text] [Related]
9. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
11. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
[TBL] [Abstract][Full Text] [Related]
12. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
Cantarovich D; Renou M; Megnigbeto A; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Karam G; Soulillou JP
Transplantation; 2005 Jan; 79(1):72-8. PubMed ID: 15714172
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients.
Oztürk S; Ayna TK; Cefle K; Palanduz S; Ciftçi HS; Kaya SA; Diler AS; Türkmen A; Gürtekin M; Sever MS; Carin M
Genet Test; 2008 Sep; 12(3):427-30. PubMed ID: 18752452
[TBL] [Abstract][Full Text] [Related]
16. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
18. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Raofi V; Holman DM; Coady N; Vazquez E; Dunn TB; Bartholomew AM; Pollak R; Benedetti E
Am J Surg; 1999 Apr; 177(4):299-302. PubMed ID: 10326847
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus in transplant rejection.
Rath T
Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]